Lyda Osorio Explained

Lyda Osorio
Nationality:Colombian
Fields:Epidemiology, Infectious disease, Vector-borne disease
Workplaces:Universidad del Valle, CIDEIM
Alma Mater:Universidad de Caldas (MD), London School of Hygiene and Tropical Medicine (PhD)
Thesis Title:Effects of mobility on the transmission of malaria in an urban area in Colombia
Doctoral Advisor:Prof. David Bradley

Lyda Elena Osorio Amaya is a Colombian physician, epidemiologist and infectious disease specialist.[1] She is an associate professor at the Universidad del Valle, and a researcher at the Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) in Cali, Valle del Cauca. Osorio's research has focused mainly on vector-borne diseases like malaria, leishmaniasis, Zika and dengue fever. She has also played a role in Colombia's response against COVID-19.

Education

Osorio studied medicine at the Universidad de Caldas. She then went on to do her 'mandatory social service' at CIDEIM for the final part of her medical degree. Osorio was awarded a scholarship from Colciencias (Colombian government) to pursue a PhD in Epidemiology at the London School of Hygiene and Tropical Medicine.[2] She graduated in 2003, with a doctoral thesis on the effects of human movement on the transmission of malaria in the Colombian city of Quibdó, which is endemic for Plasmodium falciparum and P. vivax.[3] [4] [5]

Career

Osorio became an associate professor at the School of Public Health of the Universidad del Valle (UVAL) in 2007.[6] Between 2014 and 2016, Osorio acted as the director of postgraduate programmes, and in 2018 she became the coordinator of the MSc epidemiology program, at the same University. She conducts research at the Epidemiology and Population Health group at UVAL,[7] and is an associated researcher with CIDEIM.[8]

In general her research has focused on the epidemiology, diagnosis and treatment of vector-borne diseases.[9] In 2013, Osorio applied for and won a WHO/TDR fellowship to work at GSK's Diseases of the Developing World programme as a postdoctoral fellow. During her year at GSK she worked on a trial evaluating tafenoquine against P. vivax malaria, and on clinical data from a trial studying G6PD deficiency.[10] Osorio is a Data Access Committee member of the Worldwide Antimalarial Resistance Network (WWARN).[11] As part of the WWARN's gametocyte study group, she co-authored a meta-analysis of individual patient data to look at the effects of artemisinin combination therapy in gametocyte carriage.[12]

In 2016, Osorio co-led a multi-center case-control study called Neurovirus Emerging in the Americas Study (NEAS), sponsored by Johns Hopkins University, which aimed to characterize the development of neurological symptoms after exposure to dengue, chikungunya and Zika.[13] [14] Results from this clinical trial supported the suspected development Guillain–Barré syndrome as a consequence of infection with the Zika virus.[15] Osorio's further work in Zika has included the evaluation of personal protection measures by pregnant women and women of reproductive age in Colombia against the Aedes mosquito vector.[16] She has also worked with dengue diagnosis in Colombia,[17] [18] [19] and participated in clinical trials evaluating the use of meglumine antimoniate versus miltefosine for the treatment of cutaneous leishmaniasis in adults and children.[20] [21]

Work during the COVID-19 pandemic

Osorio has also played a role in Colombia's response against COVID-19. She was designated by the mayor of Cali as the "city's epidemiologist" to help the local Health Department's planning of adequate measures against the pandemic.[22] Osorio is one of several scientists communicating with the Colombian government about strategies to control the spread of the new coronavirus,[23] including a request to support universities working on diagnosis and research.[24]

Other appointments and activities

Awards and recognitions

In December 2020, Osorio received the "Order ‘Confederate Cities’ in the rank of Commander Cross" on Pan American Doctor's day from the governor of Cali (Colombia) for her research and leadership during the COVID-19 pandemic in her country.[30]

For International Women's Day in 2021, Osorio was listed as one of the 15 influential women in science around the world selected by the World Health Organization; Osorio was featured for her work against infectious diseases, and her leadership during the COVID-19 pandemic in Colombia.[31] [32]

External links

Notes and References

  1. Web site: Escuela de Salud Pública - Lyda Elena Osorio Amaya. 6 April 2021. Universidad del Valle (Colombia). es.
  2. Web site: TDR Dr Lyda Osorio, Colombia. 2021-04-06. WHO.
  3. Effects of mobility on the transmission of malaria in an urban area in Colombia. London School of Hygiene and Tropical Medicine (University of London). 2003 . Osorio-Amaya LE .
  4. Osorio L, Todd J, Bradley DJ . Travel histories as risk factors in the analysis of urban malaria in Colombia . The American Journal of Tropical Medicine and Hygiene . 71 . 4 . 380–6 . October 2004 . 15516630 . 10.4269/ajtmh.2004.71.380 . 39709766 .
  5. Osorio L, Todd J, Bradley D . [Absence of asymptomatic malaria in schoolchildren of Quibdó, Chocó] . es. Biomedica: Revista del Instituto Nacional de Salud . 24 . 1 . 13–9 . March 2004 . 15239597 .
  6. Web site: TDR Bio - Dr Lyda Osorio - Amaya. 2021-04-06. profiles.tdr-global.net.
  7. Web site: 2019. Facultad de Salud. 7 April 2021. Universidad del Valle.
  8. Web site: CvLAC - RG. 2021-04-08. scienti.minciencias.gov.co. en.
  9. Osorio L, Garcia JA, Parra LG, Garcia V, Torres L, Degroote S, Ridde V . A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas . Infectious Diseases of Poverty . 7 . 1 . 87 . September 2018 . 30173662 . 6120097 . 10.1186/s40249-018-0474-8 . free .
  10. Web site: Osorio L . What academics can learn from pharmaceutical clinical research: experiences from the WHO/TDR Fellowship. 7 April 2021. TGHN. es.
  11. Web site: 2017-04-11. Dr Lyda Osorio. 2021-04-07. Worldwide Antimalarial Resistance Network. en.
  12. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data . BMC Medicine . 14 . 1 . 79 . May 2016 . 27221542 . 4879753 . 10.1186/s12916-016-0621-7 . WWARN Gametocyte Study Group . free .
  13. Web site: Clinical Trial on Encephalitis - Clinical Trials Registry - ICH GCP. 2021-04-07. ichgcp.net.
  14. Web site: Universidad Cooperativa de Colombia . Noticias UCC. 2021-04-07. www.ucc.edu.co. es-ES.
  15. Parra B, Lizarazo J, Jiménez-Arango JA, Zea-Vera AF, González-Manrique G, Vargas J, Angarita JA, Zuñiga G, Lopez-Gonzalez R, Beltran CL, Rizcala KH, Morales MT, Pacheco O, Ospina ML, Kumar A, Cornblath DR, Muñoz LS, Osorio L, Barreras P, Pardo CA . 6 . Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia . The New England Journal of Medicine . 375 . 16 . 1513–1523 . October 2016 . 27705091 . 10.1056/NEJMoa1605564 . free .
  16. Mendoza C, Jaramillo GI, Ant TH, Power GM, Jones RT, Quintero J, Alexander N, Webster J, Osorio L, Logan JG . 6 . An investigation into the knowledge, perceptions and role of personal protective technologies in Zika prevention in Colombia . PLOS Neglected Tropical Diseases . 14 . 1 . e0007970 . January 2020 . 31961867 . 7010294 . 10.1371/journal.pntd.0007970 . free .
  17. Caicedo-Borrero DM, Tovar JR, Méndez A, Parra B, Bonelo A, Celis J, Villegas L, Collazos C, Osorio L . 6 . Development and Performance of Dengue Diagnostic Clinical Algorithms in Colombia . The American Journal of Tropical Medicine and Hygiene . 102 . 6 . 1226–1236 . June 2020 . 32342839 . 7253082 . 10.4269/ajtmh.19-0722 .
  18. Tello-Cajiao ME, Osorio L . Impact of Dengue Rapid Diagnostic Tests on the Prescription of Antibiotics and Anti-Inflammatory Drugs by Physicians in an Endemic Area in Colombia . en. The American Journal of Tropical Medicine and Hygiene . 101 . 3 . 696–704 . September 2019 . 31333163 . 6726934 . 10.4269/ajtmh.19-0222 .
  19. Osorio L, Uribe M, Ardila GI, Orejuela Y, Velasco M, Bonelo A, Parra B . The use of rapid dengue diagnostic tests in a routine clinical setting in a dengue-endemic area of Colombia . Memórias do Instituto Oswaldo Cruz . 110 . 4 . 510–6 . June 2015 . 25993399 . 4501415 . 10.1590/0074-02760140359 .
  20. Castro MD, Cossio A, Velasco C, Osorio L . Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study . PLOS Neglected Tropical Diseases . 11 . 4 . e0005515 . April 2017 . 28379954 . 5393627 . 10.1371/journal.pntd.0005515 . free .
  21. Rubiano LC, Miranda MC, Muvdi Arenas S, Montero LM, Rodríguez-Barraquer I, Garcerant D, Prager M, Osorio L, Rojas MX, Pérez M, Nicholls RS, Gore Saravia N . 6 . Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children . The Journal of Infectious Diseases . 205 . 4 . 684–92 . February 2012 . 22238470 . 3266136 . 10.1093/infdis/jir816 .
  22. Web site: Intervención interdisciplinaria desde la Salud Pública. 2021-04-07. Universidad del Valle. es.
  23. Web site: 2020. Variaciones territoriales de la curva Covid – 19 en Colombia: De la eco-epidemiologia a la antropología. 7 April 2021. MinCiencias Colombia. es.
  24. Web site: Varela PW . Científicos reunidos con senadores piden apoyar a universidades con equipos y personal para aumentar muestras de Covid-19. 2021-04-08. Senado de la República de Colombia. es-ES.
  25. Web site: Consortium Members. 6 April 2021. ZikaPLAN.
  26. Wilder-Smith A, Preet R, Brickley EB, Ximenes RA, Miranda-Filho DB, Turchi Martelli CM, Araújo TV, Montarroyos UR, Moreira ME, Turchi MD, Solomon T, Jacobs BC, Villamizar CP, Osorio L, de Filipps AM, Neyts J, Kaptein S, Huits R, Ariën KK, Willison HJ, Edgar JM, Barnett SC, Peeling R, Boeras D, Guzman MG, de Silva AM, Falconar AK, Romero-Vivas C, Gaunt MW, Sette A, Weiskopf D, Lambrechts L, Dolk H, Morris JK, Orioli IM, O'Reilly KM, Yakob L, Rocklöv J, Soares C, Ferreira ML, Franca RF, Precioso AR, Logan J, Lang T, Jamieson N, Massad E . 6 . ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas . Global Health Action . 12 . 1 . 1666566 . 2019-01-01 . 31640505 . 6818126 . 10.1080/16549716.2019.1666566 .
  27. Web site: 2019-05-25. PAHO/WHO Malaria Technical Advisory Group - Current Members. 2021-04-06. Pan American Health Organization / World Health Organization. en-US.
  28. Web site: Dr Lyda Osorio Infectious Diseases Data Observatory. 2021-04-13. www.iddo.org.
  29. Web site: Editorial Board. 2021-04-06. BMJ Global Health. en.
  30. Web site: Gobernación del Valle del Cauca. Por su trabajo investigativo y aporte a la salud para contrarrestar el Coronavirus, la Gobernación condecoró a cuatro médicos de la región. 2021-04-07. www.valledelcauca.gov.co. es.
  31. Web site: Women scientists capture public attention as COVID-19 rages across the world. 2021-04-06. www.who.int. en.
  32. Book: Women in science: a storytelling showcase . World Health Organization . 2021 . 978-92-4-002189-1 . Geneva . 40–41. 10665/339981 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Lyda Osorio".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.